NCT04932161

Brief Summary

The ideal goal of the periodontal treatment is not only to prevent the progression of the disease, but also the regeneration and reconstruction of lost tissues. Many surgical techniques have been used to regenerate intrabony defects (IBD). Titanium stimulates activation of the complement system, surface binding of platelets, and platelet activation as reflected by increased levels of platelet-derived growth factor, which is a substantial promoter of bone growth. Hence we may speculate that using a bone substitute made of titanium may be positive from the perspective of bone formation in osseous defects.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 17, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 21, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

August 1, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2022

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

June 21, 2021

Status Verified

June 1, 2021

Enrollment Period

6 months

First QC Date

June 17, 2021

Last Update Submit

June 17, 2021

Conditions

Keywords

Intrabony defectsTitanium Granules

Outcome Measures

Primary Outcomes (3)

  • Clinical Attachment Level

    Assessment of clinical attachment level using UNC-15 probe at baseline and post operatively at 3 and 6 months.

    from baseline to 6 months

  • Probing Depth

    Assessment of probing depth using University of North Carolina(UNC)-15 probe at baseline and postoperatively at 3 and 6 months.

    from baseline to 6 months

  • Bone Regeneration

    Radiovisiography (RVG) will be used to assess bone regeneration achieved post operatively after 3 months and 6 months.

    at 3 months and 6 months

Secondary Outcomes (2)

  • Plaque Index

    from baseline to 6 months

  • Gingivitis

    from baseline to 6 months

Study Arms (2)

Titanium Granules as a bone graft in intrabony defects

EXPERIMENTAL

In test group, after reflection of flap and degranulation, bone graft i.e., titanium particles will be placed in the void created by the defect and sutures will be placed.

Procedure: Titanium Granules

Hydroxyapatite as a bone graft in intrabony defects

ACTIVE COMPARATOR

In control group, after reflection of flap and degranulation, bone graft i.e., hydroxyapatite will be placed in the defect and sutures will be placed.

Procedure: Hydroxyapatite

Interventions

After degranulation of the intrabony defect, titanium particles will be placed in the defect and will be sutured.

Titanium Granules as a bone graft in intrabony defects

After degranulation of the intrabony defect, hydroxyapatite will be placed in the defect and will be sutured.

Hydroxyapatite as a bone graft in intrabony defects

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Systemically healthy male and female patients of age \>18 years with two-walled or three-walled intrabony defects and probing pocket depths (PPD) of \>3mm.

You may not qualify if:

  • Medically compromised patients, patients \<18 years of age, pregnant women, heavy smokers, and patients who underwent radiotherapy or chemotherapy are excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

SVS Institute of Dental Sciences, Mahabubnagar

Hyderabad, Telangana, 509002, India

RECRUITING

MeSH Terms

Interventions

Durapatite

Intervention Hierarchy (Ancestors)

HydroxyapatitesApatitesCalcium PhosphatesPhosphatesPhosphoric AcidsPhosphorus AcidsAcids, NoncarboxylicAcidsInorganic ChemicalsCalcium CompoundsMineralsPhosphorus Compounds

Central Study Contacts

R V Chandra, MDS;DNB;PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Primary Investigator

Study Record Dates

First Submitted

June 17, 2021

First Posted

June 21, 2021

Study Start

August 1, 2021

Primary Completion

February 1, 2022

Study Completion

December 1, 2022

Last Updated

June 21, 2021

Record last verified: 2021-06

Locations